FDA Drug · D-0758-2026

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Class III · Ongoing

Failed Dissolution Specifications

Affected lots / codes — check yours against thisLot # 2075801, Exp Date: 31-Oct-2029.

Recalling firm: Supernus Pharmaceuticals, Inc., Rockville, MD
Classification: Class III (unlikely to cause harm)
Status: Ongoing
Quantity: 15,853 bottles
Distribution: US Nationwide.
Recall initiated: July 6, 2026
Classified: August 11, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0758-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →